Stockreport

Denali Therapeutics Inc. (DNLI) Discusses FDA Approval and Commercial Launch Plans for AVLAYAH for Hunter Syndrome Transcript [Seeking Alpha]

Denali Therapeutics Inc.  (DNLI) 
Last denali therapeutics inc. earnings: 8/6 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.denalitherapeutics.com
PDF Company Participants Laura Hansen Ryan Watts - Co-Founder, President, CEO & Director Peter Chin - Acting Chief Medical Officer & Head of Development Katie Peng [Read more]